DANITA G VANDERKODDE

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant GRAND RAPIDS, MI NPI 1891996294

General Payments — all program years on this page

$8,452.48

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,633.45 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $825.4719
Consulting Fee $750.001
Education $57.981

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $179.144
2022 $1,627.1516
2023 $5,012.7434
2024 $1,633.4521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087388104 Novartis Pharmaceuticals Corporation $32.68 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087388106 Novartis Pharmaceuticals Corporation $19.73 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087388108 Novartis Pharmaceuticals Corporation $16.27 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093926738 Alexion Pharmaceuticals, Inc. $15.10 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093984266 Alexion Pharmaceuticals, Inc. $24.86 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094027607 Alexion Pharmaceuticals, Inc. $124.99 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101105666 Celgene Corporation $20.79 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101105670 Celgene Corporation $33.61 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104853194 Biogen, Inc. $50.87 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104868016 Biogen, Inc. $23.60 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120257892 EMD Serono, Inc. $20.54 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120271274 EMD Serono, Inc. $16.94 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120279614 EMD Serono, Inc. $57.98 07/16/2024 Education Undisputed 01/23/2026 View at CMS
1133153977 Genentech USA, Inc. $31.36 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133153981 Genentech USA, Inc. $95.67 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136874765 TG Therapeutics, Inc. $94.82 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136874801 TG Therapeutics, Inc. $750.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1136874807 TG Therapeutics, Inc. $45.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136874839 TG Therapeutics, Inc. $14.39 12/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136874863 TG Therapeutics, Inc. $25.25 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136874895 TG Therapeutics, Inc. $119.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.